1. Home
  2. SYF vs DGX Comparison

SYF vs DGX Comparison

Compare SYF & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synchrony Financial

SYF

Synchrony Financial

HOLD

Current Price

$72.48

Market Cap

25.6B

Sector

Finance

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$206.54

Market Cap

23.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYF
DGX
Founded
1932
1967
Country
United States
United States
Employees
20000
N/A
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.6B
23.2B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
SYF
DGX
Price
$72.48
$206.54
Analyst Decision
Buy
Buy
Analyst Count
19
13
Target Price
$84.83
$214.38
AVG Volume (30 Days)
3.5M
739.4K
Earning Date
04-21-2026
04-21-2026
Dividend Yield
1.60%
1.82%
EPS Growth
N/A
13.78
EPS
N/A
2.24
Revenue
N/A
$11,035,000,000.00
Revenue This Year
$84.92
$7.53
Revenue Next Year
$5.11
$3.77
P/E Ratio
$7.85
$92.28
Revenue Growth
N/A
11.78
52 Week Low
$63.08
$165.78
52 Week High
$88.77
$219.20

Technical Indicators

Market Signals
Indicator
SYF
DGX
Relative Strength Index (RSI) 45.66 50.80
Support Level $71.85 $192.64
Resistance Level $75.15 $211.00
Average True Range (ATR) 2.33 4.89
MACD -0.26 -0.75
Stochastic Oscillator 45.55 29.18

Price Performance

Historical Comparison
SYF
DGX

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: